Terms: = Brain cancer AND BCL2, Bcl-2, 596, ENSG00000171791 AND Clinical Outcome
25 results:
1. A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromes.
Mongiorgi S; De Stefano A; Ratti S; Indio V; Astolfi A; Casalin I; Pellagatti A; Paolini S; Parisi S; Cavo M; Pession A; McCubrey JA; Suh PG; Manzoli L; Boultwood J; Finelli C; Cocco L; Follo MY
Clin Epigenetics; 2023 Feb; 15(1):27. PubMed ID: 36803590
[TBL] [Abstract] [Full Text] [Related]
2. Clinicopathological Characterization of Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System.
Woo HY; Chae SW; DO SI; Na K
Anticancer Res; 2022 Nov; 42(11):5601-5608. PubMed ID: 36288864
[TBL] [Abstract] [Full Text] [Related]
3. SOCS5 contributes to temozolomide resistance in glioblastoma by regulating bcl-2-mediated autophagy.
Yu J; Han L; Yang F; Zhao M; Zhou H; Hu L
Bioengineered; 2022 Jun; 13(6):14125-14137. PubMed ID: 35730472
[TBL] [Abstract] [Full Text] [Related]
4. Impact of a preceding radiotherapy on the outcome of immune checkpoint inhibition in metastatic melanoma: a multicenter retrospective cohort study of the DeCOG.
Knispel S; Stang A; Zimmer L; Lax H; Gutzmer R; Heinzerling L; Weishaupt C; Pföhler C; Gesierich A; Herbst R; Kaehler KC; Weide B; Berking C; Loquai C; Utikal J; Terheyden P; Kaatz M; Schlaak M; Kreuter A; Ulrich J; Mohr P; Dippel E; Livingstone E; Becker JC; Weichenthal M; Chorti E; Gronewold J; Schadendorf D; Ugurel S
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32371460
[TBL] [Abstract] [Full Text] [Related]
5. Overexpression of G-protein-coupled receptors 65 in glioblastoma predicts poor patient prognosis.
Wang HX; Chen YH; Zhou JX; Hu XY; Tan C; Yan Y; Huang QL; Shen JY; Xu HC; Li F; Gong ZY; Xu T; Chen JX
Clin Neurol Neurosurg; 2018 Jan; 164():132-137. PubMed ID: 29223793
[TBL] [Abstract] [Full Text] [Related]
6. p53 upregulated modulator of apoptosis sensitizes drug-resistant U251 glioblastoma stem cells to temozolomide through enhanced apoptosis.
Miao W; Liu X; Wang H; Fan Y; Lian S; Yang X; Wang X; Guo G; Li Q; Wang S
Mol Med Rep; 2015 Jun; 11(6):4165-73. PubMed ID: 25625235
[TBL] [Abstract] [Full Text] [Related]
7. Solitary fibrous tumor of the central nervous system: report of 2 cases and review of literature.
Wen G; Li M; Xu L; Hu P; Liao X; Lin C; Zhao L
Int J Clin Exp Pathol; 2014; 7(6):3444-8. PubMed ID: 25031774
[TBL] [Abstract] [Full Text] [Related]
8. Inhibition of STAT3 reverses alkylator resistance through modulation of the AKT and β-catenin signaling pathways.
Wang Y; Chen L; Bao Z; Li S; You G; Yan W; Shi Z; Liu Y; Yang P; Zhang W; Han L; Kang C; Jiang T
Oncol Rep; 2011 Nov; 26(5):1173-80. PubMed ID: 21887474
[TBL] [Abstract] [Full Text] [Related]
9. Adenovirus-mediated transfer of siRNA against basic fibroblast growth factor mRNA enhances the sensitivity of glioblastoma cells to chemotherapy.
Feng X; Zhang B; Wang J; Xu X; Lin N; Liu H
Med Oncol; 2011 Mar; 28(1):24-30. PubMed ID: 20221717
[TBL] [Abstract] [Full Text] [Related]
10. Medulloblastomas: a correlative study of MIB-1 proliferation index along with expression of c-Myc, ERBB2, and anti-apoptotic proteins along with histological typing and clinical outcome.
Das P; Puri T; Suri V; Sharma MC; Sharma BS; Sarkar C
Childs Nerv Syst; 2009 Jul; 25(7):825-35. PubMed ID: 19444455
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic value of tumor microinvasion and metalloproteinases expression in intracranial pediatric ependymomas.
Snuderl M; Chi SN; De Santis SM; Stemmer-Rachamimov AO; Betensky RA; De Girolami U; Kieran MW
J Neuropathol Exp Neurol; 2008 Sep; 67(9):911-20. PubMed ID: 18716553
[TBL] [Abstract] [Full Text] [Related]
12. Gemistocytes in astrocytomas: are they a significant prognostic factor?
Martins DC; Malheiros SM; Santiago LH; Stávale JN
J Neurooncol; 2006 Oct; 80(1):49-55. PubMed ID: 16645716
[TBL] [Abstract] [Full Text] [Related]
13. Apoptotic markers for primary brain tumor prognosis.
Konstantinidou AE; Korkolopoulou P; Patsouris E
J Neurooncol; 2005 Apr; 72(2):151-6. PubMed ID: 15925995
[TBL] [Abstract] [Full Text] [Related]
14. Dexamethasone protected human glioblastoma U87MG cells from temozolomide induced apoptosis by maintaining Bax:bcl-2 ratio and preventing proteolytic activities.
Das A; Banik NL; Patel SJ; Ray SK
Mol Cancer; 2004 Dec; 3(1):36. PubMed ID: 15588281
[TBL] [Abstract] [Full Text] [Related]
15. Pediatric intracranial ependymomas: prognostic relevance of histological, immunohistochemical, and flow cytometric factors.
Zamecnik J; Snuderl M; Eckschlager T; Chanova M; Hladikova M; Tichy M; Kodet R
Mod Pathol; 2003 Oct; 16(10):980-91. PubMed ID: 14559980
[TBL] [Abstract] [Full Text] [Related]
16. A comparative study of classical vs. desmoplastic medulloblastomas.
Pramanik P; Sharma MC; Mukhopadhyay P; Singh VP; Sarkar C
Neurol India; 2003 Mar; 51(1):27-34. PubMed ID: 12865511
[TBL] [Abstract] [Full Text] [Related]
17. Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor.
Chang J; Clark GM; Allred DC; Mohsin S; Chamness G; Elledge RM
Cancer; 2003 Feb; 97(3):545-53. PubMed ID: 12548595
[TBL] [Abstract] [Full Text] [Related]
18. Bcl-xL antisense oligonucleotides chemosensitize human glioblastoma cells.
Guensberg P; Wacheck V; Lucas T; Monia B; Pehamberger H; Eichler HG; Jansen B
Chemotherapy; 2002 Sep; 48(4):189-95. PubMed ID: 12218266
[TBL] [Abstract] [Full Text] [Related]
19. Expression of bcl-2 family member Bid in normal and malignant tissues.
Krajewska M; Zapata JM; Meinhold-Heerlein I; Hedayat H; Monks A; Bettendorf H; Shabaik A; Bubendorf L; Kallioniemi OP; Kim H; Reifenberger G; Reed JC; Krajewski S
Neoplasia; 2002; 4(2):129-40. PubMed ID: 11896568
[TBL] [Abstract] [Full Text] [Related]
20. TP53 gene mutations, nuclear p53 accumulation, expression of Waf/p21, bcl-2, and CD95 (APO-1/Fas) proteins are not prognostic factors in de novo glioblastoma multiforme.
Kraus JA; Wenghoefer M; Glesmann N; Mohr S; Beck M; Schmidt MC; Schröder R; Berweiler U; Roggendorf W; Diete S; Dietzmann K; Heuser K; Müller B; Fimmers R; von Deimling A; Schlegel U
J Neurooncol; 2001 May; 52(3):263-72. PubMed ID: 11519857
[TBL] [Abstract] [Full Text] [Related]
[Next]
